WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004035543) TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/035543    International Application No.:    PCT/IB2003/004505
Publication Date: 29.04.2004 International Filing Date: 10.10.2003
Chapter 2 Demand Filed:    02.12.2003    
IPC:
C07D 215/42 (2006.01), C07D 215/44 (2006.01), C07D 315/00 (2006.01), C07D 401/06 (2006.01), C07D 401/10 (2006.01), C07D 401/14 (2006.01), C07D 405/06 (2006.01), C07D 409/06 (2006.01), C07D 413/06 (2006.01), C07D 417/06 (2006.01), C07D 471/04 (2006.01)
Applicants: WARNER-LAMBERT COMPANY LLC [US/US]; 201 Tabor Road, Morris Plains, NJ 07950 (US) (For All Designated States Except US).
AWAD, Mohamed, Mohamed Ali [US/US]; (US) (For US Only).
BAZIN, Marc [FR/US]; (US) (For US Only).
FERU, Frederic [FR/US]; (US) (For US Only).
GOLDSTEIN, Steven, Wayne [US/US]; (US) (For US Only).
KUHN, Cyrille, François [FR/US]; (US) (For US Only)
Inventors: AWAD, Mohamed, Mohamed Ali; (US).
BAZIN, Marc; (US).
FERU, Frederic; (US).
GOLDSTEIN, Steven, Wayne; (US).
KUHN, Cyrille, François; (US)
Agent: RUDDOCK, Keith; Pfizer Limited, European Pharma Patent Dept., Ramsgate Road, Sandwich, Kent CT13 9NJ (GB)
Priority Data:
02292606.7 21.10.2002 EP
60/434,896 19.12.2002 US
Title (EN) TETRAHYDROQUINOLINE DERIVATIVES AS CRTH2 ANTAGONISTS
(FR) DERIVES DE TETRAHYDROQUINOLINE ANTAGONISTES DE CRTH2
Abstract: front page image
(EN)The invention relates to compounds of formula (I) wherein Rl, R2, R3, R4, R5, R6, R7 and R8 are as defined in the description, their use as medicament, pharmaceutical compositions containing them and processes for their preparation.
(FR)L'invention concerne des composés de formule (I) dans laquelle R1, R2, R3, R4, R5, R6, R7 et R8 sont tels que définis dans la description, leur utilisation en tant que médicament, des compositions pharmaceutiques les contenant et des procédés de leur préparation.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)